Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496593PMC
http://dx.doi.org/10.1007/s10147-021-01940-wDOI Listing

Publication Analysis

Top Keywords

correction clinical
4
clinical eribulin
4
eribulin first-
4
first- second-line
4
second-line chemotherapy
4
chemotherapy recurrent
4
recurrent her2-negative
4
her2-negative breast
4
breast cancer
4
cancer randomized
4

Similar Publications

Background: The aim is to develop age-specific anti-Müllerian hormone screening criteria for polycystic ovary syndrome to facilitate the early detection and diagnosis of the condition, and to subsequently evaluate the screening criteria.

Methods: A retrospective analysis was performed on patient data from Hangzhou Women's Hospital between July 2021 and August 2024. The use of restricted cubic spline analysis helped identify age-related inflection points, which were crucial for segmenting the patient population.

View Article and Find Full Text PDF

Ultraportable (UP) X-ray devices are ideal to use in community-based settings, particularly for chest X-ray (CXR) screening of tuberculosis (TB). Unfortunately, there is insufficient guidance on the radiation safety of these devices. This study aims to determine the radiation dose by UP X-ray devices to both the public and radiographers compared to international dose limits.

View Article and Find Full Text PDF

There is different administration routes of triamcinolone acetonide (TA) administration for macular edema, but the efficacy ranking remains unclear. The purpose of this study is to assess the efficacy of different administration routes of TA employed in macular edema. PubMed, Medline, Embase, and Cochrane Central Register of Controlled Trials were systematically searched for published articles comparing macular edema in patients with triamcinolone acetonide in different administration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!